Eloxx finalizes Phase 2 ADPKD trial design, names new CMO
Go back to Eloxx finalizes Phase 2 ADPKD trial design, names new CMO| (NASDAQ: ELOX) | Delayed: 13.56 +0.26 (1.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.30 | 52 Week High | $ | |||
| Open | $13.21 | 52 Week Low | $ | |||
| Day High | $13.56 | P/E | N/A | |||
| Day Low | $12.84 | EPS | $ | |||
| Volume | 1,819 | |||||



